Anas Younes, Chief Medical Officer and Head of Haematology R&D at AstraZeneca, shared on LinkedIn:
“As a clinician-scientist, what matters most to me is providing the opportunity to improve outcomes for people living with blood cancer.
Listening to patients and the communities that support them helps us better understand what matters most to those affected by blood cancer.
Patient advocacy groups play a vital role in raising awareness, providing support, and helping ensure patient needs remain at the center of progress in hematology.
This Blood Cancer Awareness Month, I invite you to scroll through some of the impactful initiatives led by patient advocacy groups and thank them for the important contributions they make to the blood cancer community.”
Check the media photos below.
You can also read: AstraZeneca Marks Blood Cancer Awareness Month With Focus on CLL Community
